Skip to main content
. 2021 Jun 2;8:661752. doi: 10.3389/fmed.2021.661752

Table 3.

Incidence and adjusted hazard ratio of inflammatory bowel disease based on follow-up period for patients with appendectomy compared with controls.

Appendectomy Compared to control
Yes No
Variables Events PY Rate# Events PY Rate# Crude HR (95% CI) Adjusted HR (95% CI)
All
Follow-up time, years
   <3 131 678,513 19.3 31 685,753 4.52 4.26 (2.88, 6.31)*** 3.99 (2.69, 5.91)***
  3–6 64 504,262 12.7 22 512,187 4.30 2.96 (1.82, 4.80)*** 2.67 (1.64, 4.35)***
  >6 60 555,167 10.8 34 568,921 5.98 1.81 (1.19, 2.75)** 1.74 (1.14, 2.66)*
Ulcerative colitis (UC)
Follow-up time, years
   <3 54 7.96 15 2.19 3.63 (2.05, 6.44)*** 3.30 (1.85, 5.88)***
  3–6 32 6.35 11 2.15 2.96 (1.49, 5.86)** 2.67 (1.34, 5.34)**
  >6 30 5.40 23 4.04 1.34 (0.78, 2.30) 1.28 (0.74, 2.22)
Crohn's disease (CD)
Follow-up time, years
   <3 77 11.4 16 2.33 4.85 (2.83, 8.32)*** 4.58 (2.67, 7.87)***
  3–6 32 6.35 11 2.15 2.95 (1.49, 5.86)** 2.65 (1.33, 5.29)**
  >6 30 5.40 11 1.93 2.80 (1.40, 5.58)** 2.69 (1.34, 5.40)**

Rate#, Incidence rate per 10,000 person-years; Crude HR, relative hazard ratio;

Adjusted HR, adjusted hazard ratio after control for age, sex, and comorbidities of CAD, hypertension, diabetes, hyperlipidemia, CVA, heart failure, COPD, CKD, alcohol-related diseases, cirrhosis, and biliary stone.

CAD, coronary artery disease; CI, confidence interval; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular disease; PY, person years; SD, standard deviation.

*

P < 0.05,

**

P < 0.01,

***

P < 0.001.